Noticias de Eulerpool Hansoh Pharmaceutical Group Company

Hansoh Pharmaceutical Group Company Eulerpool-AFX

Hansoh Pharmaceutical Group Company Noticias de Acciones

Hansoh Pharmaceutical Group Company es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Hansoh Pharmaceutical Group Company.

• 17 de marzo ·

  SeekingAlpha
  Week In Review: Under Pressure From U.S. Congress, WuXi AppTec Resigns From BIO
• 14 de marzo ·

  Yahoo
  Health Care Roundup: Market Talk
• 24 de febrero ·

  SeekingAlpha
  Silence Therapeutics: Multiple 2024 Catalysts Make This mRNA Biotech Worth A Look
• 29 de octubre ·

  SeekingAlpha
  Week In Review: Hansoh Sells Ex-China ADC Rights To GSK In $1.6 Billion Deal
• 13 de agosto ·

  SeekingAlpha
  Week In Review: BeiGene And BMS Close BeiGene-Celgene PD-1 Partnership
• 20 de julio ·

  Yahoo
  SCYNEXIS and Hansoh Pharma Announce NMPA Acceptance of the New Drug Application for Ibrexafungerp in China
• 14 de marzo ·

  SeekingAlpha
  Silence Therapeutics: Breaking The Silence On An Under-The-Radar Mid-Stage SiRNA Platform
• 21 de noviembre ·

  SeekingAlpha
  Week In Review: Fosun Signs $840 Million Deal For U.S. Rights To Henlius' PD-1
• 3 de octubre ·

  SeekingAlpha
  Week In Review: YishengBio To List On Nasdaq Via SPAC Merger At An $834 Million Value
• 26 de septiembre ·

  Yahoo
  KiOmed Pharma and Hansoh Pharma Announce License Agreement for KiOmedinevsOne in China’s Mainland, Macau and Taiwan